Prognostic and Predictive Value of Metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 Phase III Trial of Pembrolizumab Versus Placebo in Resected High-Risk Stage III MelanomaOliver John Kennedy,Michal Kicinski,Sara Valpione,Sara Gandini,Stefan Suciu,Christian U. Blank,Georgina Long,Victoria G. Atkinson,Stephane Dalle,Andrew M. Haydon,Andrey Meshcheryakov,Adnan Khattak,Matteo S. Carlino,Shahneen Sandhu,James Larkin,Susana Puig,Paolo A. Ascierto,Piotr Rutkowski,Dirk Schadendorf,Marye Boers-Sonderen,Anna Maria Di Giacomo,Alfonsus J. M. van den Eertwegh,Jean-Jacques Grob,Ralf Gutzmer,Rahima Jamal,Alexander C. J. van Akkooi,Caroline Robert,Alexander M. M. Eggermont,Paul Lorigan,Mario MandalaEUROPEAN JOURNAL OF CANCER（2023）引用 34|浏览47关键词Melanoma,Immunotherapy,Metformin,Immunomodulation,BRAFAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
